Naviscan
acquired by CMR NaviscanCarlsbad, US · 1 known investors
CMR Naviscan develops a breast imaging technology aimed at improving invasive cancer detection rates and reducing unnecessary biopsies, particularly in women with dense breast tissue. It positions its modality as a lower-cost alternative that addresses limitations of existing breast cancer screening methods.
Investors · 1
Competitors · 2
by search overlapAmerican Cancer Society (ACS)4 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
Doximity3 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
Companies competing with Naviscan for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Naviscan do?
- CMR Naviscan develops a breast imaging technology aimed at improving invasive cancer detection rates and reducing unnecessary biopsies, particularly in women with dense breast tissue. It positions its modality as a lower-cost alternative that addresses limitations of existing breast cancer screening methods.
- Who are Naviscan's investors?
- Naviscan's investors include Sanderling Ventures.
- Who acquired Naviscan?
- Naviscan was acquired by CMR Naviscan.
- Where is Naviscan headquartered?
- Naviscan is headquartered in Carlsbad, US.